While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Great things are happening to the stocks in this article.
They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
The F-150 Lightning line may be shut down for good. That’s a bit of an exaggeration, but not much. In October, Ford sold just 1,500 Lightnings, the fewest of any model.
As the US strives to keep its lead in the AI race, the Trump administration has continued to tighten restrictions on the export of high-performance chips.
September’s retail sales and industry data did not cause any confusion, as the overall picture remained unchanged. Retail sales volumes continued to increase, while industrial production continued to trend down on a yearly basis
As Tapestry has significantly outperformed the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
This article argues that high-skilled immigration is a strong driver of economic growth, innovation, and job creation—benefitting both native workers and the broader economy.
Let’s dig into the relative performance of First Financial Bancorp (NASDAQ:FFBC) and its peers as we unravel the now-completed Q3 regional banks earnings season.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how automobile manufacturing stocks fared in Q3, starting with Lucid (NASDAQ:LCID).
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its peers.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how online retail stocks fared in Q3, starting with Amazon (NASDAQ:AMZN).
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at drug development inputs & services stocks, starting with West Pharmaceutical Services (NYSE:WST).
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the regional banks industry, including Merchants Bancorp (NASDAQ:MBIN) and its peers.
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the electronic components & manufacturing stocks, including Rogers (NYSE:ROG) and its peers.
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Repligen (NASDAQ:RGEN) and its peers.
Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL) subsidiary Google said Thursday it will integrate prediction market data from Polymarket and Kalshi on its Google Finance platform.
We’re a 2-sided market now, and these conditions will chop you up if you’re not prepared. Don’t you worry, though, this 2-Sided Strategy is perfect for Friday morning!
Despite Trimble’s underperformance relative to the broader market over the past year, Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.
Unlike Palantir or Robinhood, which seem to be trading more on narrative and sentiment swings, AppLovin is delivering tangible growth backed by expanding margins and massive free cash flow.
Notable IPOs have finally started hitting the tape in 2025, reflecting a meaningful shift in sentiment. Both CRCL and CRWV shares are up from their initial debuts, though CRCL has seen much of its IPO gains evaporate.
In this video, Ira Epstein discusses the current state of the SPDR ETF stock market, noting that a correction phase is occurring as of November 6th, 2025.
Quantum tech hype is cooling — once high-flying stocks are faltering, suggesting the market may be rethinking the timing and scale of the next quantum computing revolution.
Prospect Capital (PSEC) Q1 2025 earnings beat NII estimates at $0.17 per share. Investment income of $157.6M missed forecasts. Stock rose 1.18% post-release.
eXp World Holdings (EXPI) Q3 2025 earnings beat revenue estimates and met profit forecasts, driving a positive market reaction and highlighting steady growth.
GBP/USD rose Thursday as bearish momentum eased and a close BoE vote on rates fueled hopes of support for the UK’s slowing economy, even as inflation remains elevated.
Brighthouse Financial's Q3 2025 results show mixed performance, with earnings beating estimates but revenue falling short. The insurer saw strong annuity sales and improved life segment results.
DraftKings Q3 2025 revenue misses estimates, leading to a stock drop. The company posted a narrower loss per share but lowered its full-year revenue guidance.
ICU Medical (ICUI) Q3 2025 earnings crush estimates with EPS of $2.03, beating forecasts by 41.6%. The company also raised its full-year outlook, sparking a 10%+ stock surge.
